ArticleTargeted oncology2015

Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack.

Marc Cinci et al.PubMed ↗Publisher ↗

No numbers read from the abstract.